Prioritizing noncommunicable diseases in the Americas region in the era of Covid-19

Bibliographic Data

ID14967154
AuthorsSilvana Luciani (0000-0002-3122-1258, World Health Organization Regional Office for the Americas, corresponding author), Irene Agurto (World Health Organization Regional Office for the Americas), Roberta Caixeta (0000-0003-3943-8176, World Health Organization Regional Office for the Americas), Anselm Hennis (0000-0002-2400-3463, World Health Organization Regional Office for the Americas)
Year2022
Volume46
Pages1
Publication date2022-07-20
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueRevista Panamericana de Salud Pública (JOURNAL)
Journal identifiersISSN: 1020-4989 • E-ISSN: 1680-5348
PublisherPan American Health Organization (PUBLISHER • US)
DOI10.26633/rpsp.2022.83
PMID35875322
OpenAlexW4286007679
LanguageEN
Citations received6
References cited15

This article describes the situation of noncommunicable diseases (NCDs) in the Americas, implementation of NCD interventions according to key progress indicators, the impact of COVID-19 on NCD services, and ways to reprioritize NCDs following COVID-19. Information was retrieved from institutional data and through a supplementary scoping review of published articles related to NCDs and COVID-19 in the Americas published April 2020–November 2021. While NCDs account for 80.7% of all deaths in the Americas, implementation of a key set of NCD interventions has been limited, with only three countries reporting implementation of 12 or more of the 19 NCD indicators. By mid-May 2022, the Americas had reported about 29.9% of all COVID-19 cases in the world (154 million of 515 million) and 43.5% all COVID-19 deaths (2.7 million of 6.2 million). This pandemic has hampered progress on NCDs and significantly disrupted services for people who require ongoing care. Adaptive strategies, such as telehealth and mobile pharmacies, have been used to mitigate service disruptions. However, NCD prevention and management must be an integral part of recovering from the COVID-19 pandemic. This will require scaled up efforts to establish/re-establish and enforce policies on NCD risk factors, especially for tobacco control and obesity prevention, as well as greater investment in primary care and expansion of telemedicine and digital health solutions for continuous care for people with NCDs. Lastly, limited data are available on the impact of COVID-19 on NCDs, and hence NCD data and surveillance need to be strengthened

Business · Coronavirus disease 2019 (COVID-19 · Disease · Economic growth · Environmental health · Health care · Pandemic · Psychological intervention · Telehealth · Telemedicine · Global Public Health Policies and Epidemiology · Medicine · Nursing · Obesity, Physical Activity, Diet · Public Health and Social Inequalities

Tools

Open DOIOpen Access